Griffioen AW - Search Results

1

Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.

Hillen F, Baeten CI, van de Winkel A, Creytens D, van der Schaft DW, Winnepenninckx V, Griffioen AW. Hillen F, et al. Among authors: griffioen aw. Cancer Immunol Immunother. 2008 Jan;57(1):97-106. doi: 10.1007/s00262-007-0353-9. Epub 2007 Jun 30. Cancer Immunol Immunother. 2008. PMID: 17602225

2

Angiogenesis, a target for tumor therapy.

Griffioen AW, Barendsz-Janson AF, Mayo KH, Hillen HF. Griffioen AW, et al. J Lab Clin Med. 1998 Nov;132(5):363-8. doi: 10.1016/s0022-2143(98)90106-8. J Lab Clin Med. 1998. PMID: 9823929 Review. No abstract available.

3

Tumor angiogenesis factors reduce leukocyte adhesion in vivo.

Tromp SC, oude Egbrink MG, Dings RP, van Velzen S, Slaaf DW, Hillen HF, Tangelder GJ, Reneman RS, Griffioen AW. Tromp SC, et al. Among authors: griffioen aw. Int Immunol. 2000 May;12(5):671-6. doi: 10.1093/intimm/12.5.671. Int Immunol. 2000. PMID: 10784613

4

Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

Griffioen AW, Molema G. Griffioen AW, et al. Pharmacol Rev. 2000 Jun;52(2):237-68. Pharmacol Rev. 2000. PMID: 10835101 Review.

5

Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment.

Baeten CI, Wagstaff J, Verhoeven IC, Hillen HF, Griffioen AW. Baeten CI, et al. Among authors: griffioen aw. Br J Cancer. 2002 Jul 29;87(3):344-7. doi: 10.1038/sj.bjc.6600457. Br J Cancer. 2002. PMID: 12177806 Free PMC article.

6

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Among authors: griffioen aw. FASEB J. 2002 Dec;16(14):1991-3. doi: 10.1096/fj.02-0509fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397082

7

Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity.

Ahmed B, Van Eijk LI, Bouma-Ter Steege JC, Van Der Schaft DW, Van Esch AM, Joosten-Achjanie SR, Lambin P, Landuyt W, Griffioen AW. Ahmed B, et al. Among authors: griffioen aw. Int J Cancer. 2003 May 20;105(1):20-5. doi: 10.1002/ijc.11010. Int J Cancer. 2003. PMID: 12672025

8

Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.

Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, Wagstaff J, Griffioen AW. Dirkx AE, et al. Among authors: griffioen aw. Cancer Res. 2003 May 1;63(9):2322-9. Cancer Res. 2003. PMID: 12727857

9

The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions.

Griffioen AW, Relou IA, Gallardo Torres HI, Damen CA, Martinotti S, De Graaf JC, Zwaginga JJ, Groenewegen G. Griffioen AW, et al. Angiogenesis. 1998;2(3):235-43. doi: 10.1023/A:1009237324501. Angiogenesis. 1998. PMID: 14517463

10

Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.

de Lussanet QG, Backes WH, Griffioen AW, van Engelshoven JM, Beets-Tan RG. de Lussanet QG, et al. Among authors: griffioen aw. Radiology. 2003 Nov;229(2):429-38. doi: 10.1148/radiol.2292021007. Radiology. 2003. PMID: 14595147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results